Specific B-cell Memory After a Single Dose or Booster MenC Conjugate Vaccination: a Pilot Study in Adults

Trial Profile

Specific B-cell Memory After a Single Dose or Booster MenC Conjugate Vaccination: a Pilot Study in Adults

Active, no longer recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Meningococcal vaccine group C conjugate (Primary) ; Meningococcal vaccine groups A and C polysaccharide (Primary)
  • Indications Meningococcal group A infections; Meningococcal group C infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 May 2009 Status changed from not stated to active, no longer recruiting.
    • 07 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top